Shah Metacorp Ltd extends rights issue closing date to 3 July 2026

What Shah Metacorp Ltd announced

On 24 June 2026, Shah Metacorp Ltd (BSE: 533275) disclosed that its Board of Directors had approved an extension of the rights‑issue closing date. The original deadline of Wednesday, 24 June 2026 was moved to Friday, 3 July 2026. The decision was taken to give eligible equity shareholders additional time to subscribe to the rights issue.

Details of the rights‑issue extension

The rights issue opened on 11 June 2026. Under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, a rights issue may remain open for a maximum of 30 calendar days from the opening date. The Board confirmed that the new closing date of 3 July 2026 falls within this outer limit, thereby ensuring regulatory compliance.

Key points from the filing:

• Original closing date: 24 June 2026 (Wednesday).
• Revised closing date: 3 July 2026 (Friday).
• Extension rationale: Provide an opportunity for eligible shareholders to exercise their rights.
• No amendment to issue size, price, or entitlement ratio was mentioned.

Key facts at a glance

Why this matters for investors

The rights issue gives existing shareholders the right, but not the obligation, to purchase additional shares—typically at a discount—to the company’s current shareholders. Extending the subscription window does not alter the number of shares offered, the issue price, or the dilution impact; it merely increases the time available for shareholders to decide.

For investors who may have missed the original deadline due to logistical or informational delays, the nine‑day extension can be material. It also signals that the company is attentive to shareholder participation, which can be important for meeting subscription targets and avoiding under‑subscribed capital raises.

Conclusion

Shah Metacorp Ltd’s board has formally extended the rights‑issue closing date to 3 July 2026, staying within the SEBI‑mandated 30‑day window. The amendment does not affect the issue’s size, price, or entitlement ratio, but it provides eligible shareholders additional time to subscribe. The rights issue remains subject to the usual regulatory approvals and shareholder participation thresholds.